Remnant nephron physiology and the progression of chronic kidney disease

被引:0
作者
H. William Schnaper
机构
[1] Ann and Robert H. Lurie Children’s Hospital of Chicago,Division of Kidney Diseases
[2] Northwestern University Feinberg School of Medicine,Department of Pediatrics
来源
Pediatric Nephrology | 2014年 / 29卷
关键词
Hypertrophy; Fibrosis; Reactive oxygen species; Chronic kidney disease; Nephron;
D O I
暂无
中图分类号
学科分类号
摘要
In chronic kidney disease, ongoing failure of individual nephrons leads to the progressive loss of renal function. This process results in part from a cellular and molecular response to injury that represents an attempt to maintain homeostasis but instead initiates a program that damages the nephron. As nephrons are lost, compensation by the remaining nephrons exacerbates glomerular pathophysiology. The delivery of excessive amounts of biologically active molecules to the distal nephron and tubulointerstitium generates inflammation and cellular dedifferentiation. Energy requirements of hyperfunctioning nephrons exceed the metabolic substrate available to the renal tubule, and inadequacy of the local vascular supply promotes hypoxia/ischemia and consequent acidosis and reactive oxygen species generation. In this way, mechanisms activated to maintain biological balance ultimately lead to demise of the nephron.
引用
收藏
页码:193 / 202
页数:9
相关论文
共 339 条
  • [31] Bricker NS(2009)Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD J Pharmacol Sci 109 24-384
  • [32] Fine LG(2000)Role of nitric oxide in the autoregulation of renal blood flow and glomerular filtration rate in aging spontaneously hypertensive rats Kidney Blood Press Res 23 376-6
  • [33] Kaplan M(2012)Nitric oxide synthase derangements and hypertension in kidney disease Curr Opin Nephrol Hypertens 21 1-1533
  • [34] Epstein M(2007)Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease J Am Soc Nephrol 18 1525-384
  • [35] Bourgoignie JJ(1973)Renal energy metabolism and sodium reabsorption Annu Rev Med 24 365-1626
  • [36] Light A(1992)Renal and systemic oxygen consumption in patients with normal and abnormal renal function J Am Soc Nephrol 2 1617-28
  • [37] Eddy AA(2011)Consequences and therapy of the metabolic acidosis of chronic kidney disease Pediatr Nephrol 26 19-F829
  • [38] Schnaper HW(2011)Effect of metabolic acidosis on progression of chronic kidney disease Am J Physiol Renal Physiol 300 F828-623
  • [39] Kriz W(2010)Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR Kidney Int 77 617-547
  • [40] LeHir M(2012)Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review Am J Nephrol 35 540-F837